InsiderClue
Insiders · Profile

Smith Mark Douglas

Director at Jazz Pharmaceuticals · Director at Phreesia · Director at Teladoc Health. Filing since 10 Aug 2020. CIK 0001756253

JAZZ Jazz Pharmaceuticals plc Director · 6 trades PHR Phreesia, Inc. Director · 5 trades TDOC Teladoc Health, Inc. Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
JAZZ Jazz Pharmaceuticals plc
15 Jun 2026
Director
Sold on a plan
1,157
$266.75K
10.7%
PHR Phreesia, Inc.
2 Jul 2025
Director
Sold on a plan
7,000
$203.00K
15.8%
TDOC Teladoc Health, Inc.
15 Aug 2024
Director
Bought
4,000
$28.31K
91.8%
PHR Phreesia, Inc.
18 Jul 2024
Director
Sold on a plan
7,000
$175.00K
18.6%
JAZZ Jazz Pharmaceuticals plc
4 Dec 2023
Director
Sold at will
417
$49.74K
5.7%
JAZZ Jazz Pharmaceuticals plc
14 Aug 2023
Director
Sold at will
1,241
$171.45K
14.5%
PHR Phreesia, Inc.
3 Apr 2023
Director
Sold on a plan
7,000
$215.37K
30.3%
JAZZ Jazz Pharmaceuticals plc
2 Dec 2022
Director
Sold, plan not stated
420
$64.97K
7.1%
JAZZ Jazz Pharmaceuticals plc
8 Aug 2022
Director
Sold, plan not stated
1,089
$165.88K
15.6%
JAZZ Jazz Pharmaceuticals plc
2 Dec 2021
Director
Sold, plan not stated
417
$50.58K
8.6%
PHR Phreesia, Inc.
4 Jan 2021
Director
Sold, plan not stated
6,000
$315.41K
49.5%
PHR Phreesia, Inc.
10 Aug 2020
Director
Sold, plan not stated
6,000
$181.82K
49.5%
12 decisions on file.